Results 61 to 70 of about 13,977 (112)
Extracting the past from the present: Introduction
Alexandre Livingstone Smith +6 more
doaj +1 more source
Dissecting genetic architecture of flowering and maturity traits in soybean using GWAS in Indian environment. [PDF]
Raghuvanshi R +16 more
europepmc +1 more source
Introduction au dossier « Histoires de territoires »
Marie-Laure Derat, Camille Lefebvre
doaj +1 more source
L’Afrique et l’histoire des techniques. Hommage à François Sigaut
Monique Chastanet
doaj +1 more source
Flowering time and stem growth habit determine inflorescence architecture in soybean, which in turn influences seed yield. Dt1, a homolog of Arabidopsis TERMINAL FLOWER 1 (TFL1), is a major controller of stem growth habit, but its underlying molecular ...
Chao Fang, Liyu Chen, Zhicheng Dong
exaly +2 more sources
The neurotensin subtype 1 receptor (NTS1R) is overexpressed in a number of human tumors, thereby representing a valid target for cancer theranostics with radiolabeled neurotensin (NT) analogs like [99mTc]Tc-DT1 (DT1, N4-Gly7-NT(8-13)). Thus far, the fast
Panagiotis Kanellopoulos +2 more
exaly +2 more sources
Biotransformation of tetracycline by a novel bacterial strain Stenotrophomonas maltophilia DT1
Yifei Leng, Jianguo Bao, Xu Li
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cancer Research, 2023
Mutations in BRAF and RAS are often oncogenic and lead to a constitutively active MAPK pathway that promotes aberrant cell proliferation and tumor growth. Currently approved BRAF inhibitors are selective against monomeric BRAF V600 mutants. These drugs
Yoon-Chi Han +7 more
semanticscholar +1 more source
Mutations in BRAF and RAS are often oncogenic and lead to a constitutively active MAPK pathway that promotes aberrant cell proliferation and tumor growth. Currently approved BRAF inhibitors are selective against monomeric BRAF V600 mutants. These drugs
Yoon-Chi Han +7 more
semanticscholar +1 more source

